Gaston Matthyssens, Managing Partner at Vesalius Biocapital Partners. See sector focus and contact routes.
Gaston Matthyssens, Managing Partner at Vesalius Biocapital Partners, invests in European life sciences companies active in human health, specifically targeting therapeutics, medical devices, diagnostics, and eHealth/mHealth sectors. The firm focuses on early-stage companies and corporate spin-offs with assets close to clinical trials or those possessing CE/FDA validation, prioritizing startups that address unmet medical needs. Notable portfolio companies include Forendo (acquired by Organon for $954m), Sword Health, Rejuvenate Biomed, and Inflammatix, reflecting a thesis of backing ventures capable of significantly contributing to medical challenges.
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in Strassen.
Investors like Gaston Matthyssens · Full investor directory · Investor access · Company funding database